|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US4861719A
(en)
|
1986-04-25 |
1989-08-29 |
Fred Hutchinson Cancer Research Center |
DNA constructs for retrovirus packaging cell lines
|
|
JP2779192B2
(ja)
|
1987-09-17 |
1998-07-23 |
マサチユセツツ・インスチチユート・オブ・テクノロジー |
ヒト赤血球特異的転写エンハンサー
|
|
US5278056A
(en)
|
1988-02-05 |
1994-01-11 |
The Trustees Of Columbia University In The City Of New York |
Retroviral packaging cell lines and process of using same
|
|
US5670488A
(en)
|
1992-12-03 |
1997-09-23 |
Genzyme Corporation |
Adenovirus vector for gene therapy
|
|
AU8200191A
(en)
|
1990-07-09 |
1992-02-04 |
United States of America, as represented by the Secretary, U.S. Department of Commerce, The |
High efficiency packaging of mutant adeno-associated virus using amber suppressions
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
DE69233013T2
(de)
|
1991-08-20 |
2004-03-04 |
The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer |
Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
|
|
US5487994A
(en)
|
1992-04-03 |
1996-01-30 |
The Johns Hopkins University |
Insertion and deletion mutants of FokI restriction endonuclease
|
|
US5436150A
(en)
|
1992-04-03 |
1995-07-25 |
The Johns Hopkins University |
Functional domains in flavobacterium okeanokoities (foki) restriction endonuclease
|
|
US5356802A
(en)
|
1992-04-03 |
1994-10-18 |
The Johns Hopkins University |
Functional domains in flavobacterium okeanokoites (FokI) restriction endonuclease
|
|
DE69434860T2
(de)
|
1993-02-22 |
2007-03-15 |
The Rockefeller University |
Herstellung von helfer-freien retroviren mit hohem titer mittels transienter transfektion
|
|
FR2705361B1
(fr)
|
1993-05-18 |
1995-08-04 |
Centre Nat Rech Scient |
Vecteurs viraux et utilisation en thérapie génique.
|
|
FR2712812B1
(fr)
|
1993-11-23 |
1996-02-09 |
Centre Nat Rech Scient |
Composition pour la production de produits thérapeutiques in vivo.
|
|
ATE386131T1
(de)
|
1994-04-13 |
2008-03-15 |
Univ Rockefeller |
Aav-vermittelte überbringung von dna in zellen des nervensystems
|
|
IL116816A
(en)
|
1995-01-20 |
2003-05-29 |
Rhone Poulenc Rorer Sa |
Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
US6004797A
(en)
|
1995-11-09 |
1999-12-21 |
Avigen, Inc. |
Adenovirus helper-free recombinant AAV Virion production
|
|
US6027721A
(en)
|
1996-05-20 |
2000-02-22 |
Cytotherapeutics, Inc. |
Device and method for encapsulated gene therapy
|
|
US6136597A
(en)
|
1997-09-18 |
2000-10-24 |
The Salk Institute For Biological Studies |
RNA export element
|
|
US20020065236A1
(en)
|
1998-09-09 |
2002-05-30 |
Yew Nelson S. |
CpG reduced plasmids and viral vectors
|
|
US6453242B1
(en)
|
1999-01-12 |
2002-09-17 |
Sangamo Biosciences, Inc. |
Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
|
|
US7994278B1
(en)
|
1999-08-06 |
2011-08-09 |
Nobel Biosciences Llc |
Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
|
|
HK1050210B
(en)
|
1999-10-12 |
2007-08-24 |
Institut Pasteur |
Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
|
|
US7056502B2
(en)
|
2000-04-28 |
2006-06-06 |
The Trustees Of The University Of Pennsylvania |
Recombinant aav vectors with AAV5 capsids and AAV5 vectors pseudotyped in heterologous capsids
|
|
US6627442B1
(en)
|
2000-08-31 |
2003-09-30 |
Virxsys Corporation |
Methods for stable transduction of cells with hiv-derived viral vectors
|
|
GB0024550D0
(https=)
|
2000-10-06 |
2000-11-22 |
Oxford Biomedica Ltd |
|
|
US7575924B2
(en)
|
2000-11-13 |
2009-08-18 |
Research Development Foundation |
Methods and compositions relating to improved lentiviral vectors and their applications
|
|
ATE527347T1
(de)
|
2001-08-02 |
2011-10-15 |
Inst Clayton De La Rech |
Verfahren und zusammensetzungen im zusammenhang mit verbesserten lentivirusvektor- produktionssystemen
|
|
RU2305708C2
(ru)
|
2001-10-02 |
2007-09-10 |
Энститю Клейтон Де Ля Решерш |
Рекомбинантный лентивирусный вектор, клетка-хозяин, трансдуцированная лентивирусным вектором, способ ее трансдукции и применение
|
|
MX359371B
(es)
|
2001-11-13 |
2018-09-25 |
Univ Pennsylvania |
Un metodo para detectar y/o identificar secuencias del virus adeno-asociado y aislamiento de secuencias novedosas identificadas de ese modo.
|
|
CA2483915A1
(en)
|
2002-05-02 |
2003-11-13 |
University Of Rochester |
Vectors having both isoforms of b-hexosaminidase
|
|
AU2003274397A1
(en)
|
2002-06-05 |
2003-12-22 |
University Of Florida |
Production of pseudotyped recombinant aav virions
|
|
US20060058253A1
(en)
|
2002-08-12 |
2006-03-16 |
Benoit Chabot |
Methods to reprogram splice site selection in pre-messenger rnas
|
|
ES2298745T3
(es)
|
2003-04-24 |
2008-05-16 |
Fondazione Centro San Raffaele Del Monte Tabor |
Promotores bidireccionales de sintesis y utilizacion de los mismos.
|
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
EP2345731B1
(en)
|
2003-09-30 |
2015-10-21 |
The Trustees of the University of Pennsylvania |
Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof
|
|
US20060171935A1
(en)
|
2005-01-31 |
2006-08-03 |
Asa Abeliovich |
Protecting cell therapy for neurological disorders including Parkinson's disease
|
|
US20070048285A1
(en)
|
2005-08-24 |
2007-03-01 |
Christopher Baum |
Self-inactivating retroviral vector
|
|
US7867484B2
(en)
|
2006-01-27 |
2011-01-11 |
University Of North Carolina At Chapel Hill |
Heparin and heparan sulfate binding chimeric vectors
|
|
US7588772B2
(en)
|
2006-03-30 |
2009-09-15 |
Board Of Trustees Of The Leland Stamford Junior University |
AAV capsid library and AAV capsid proteins
|
|
US8324367B2
(en)
|
2006-11-03 |
2012-12-04 |
Medtronic, Inc. |
Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
|
|
EP2333091B1
(en)
|
2007-05-29 |
2017-06-21 |
Nature Technology Corporation |
Vectors and methods for genetic immunization
|
|
EP2176283B1
(en)
|
2007-07-14 |
2016-11-02 |
University of Iowa Research Foundation |
Methods and compositions for treating brain diseases
|
|
WO2009026116A2
(en)
|
2007-08-16 |
2009-02-26 |
Genizon Biosciences, Inc. |
Genemap of the human genes associated with longevity
|
|
WO2010126766A1
(en)
|
2009-04-30 |
2010-11-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inducible interleukin-12
|
|
DE102009021592A1
(de)
|
2009-05-15 |
2010-11-18 |
Medizinische Hochschule Hannover |
ASLV-Vektorsystem
|
|
WO2011053825A2
(en)
|
2009-10-30 |
2011-05-05 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compositions and methods for the treatment or prevention of mitochondrial diseases
|
|
JP2013523776A
(ja)
|
2010-04-02 |
2013-06-17 |
セレジーン インコーポレイテッド |
パーキンソン病および脳のドーパミン作動性ニューロンのその他の障害を処置する方法
|
|
US8603994B2
(en)
*
|
2010-11-11 |
2013-12-10 |
Valted, Llc |
Transcriptional repression leading to Parkinson's disease
|
|
US9434928B2
(en)
|
2011-11-23 |
2016-09-06 |
Nationwide Children's Hospital, Inc. |
Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides
|
|
MX367100B
(es)
|
2012-02-17 |
2019-08-05 |
The Children´S Hospital Of Philadelphia |
Composiciones del vector aav y metodos para su transferencia genetica a celulas, organos y tejidos.
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
WO2013151665A2
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins associated with human disease
|
|
EP2669381A1
(en)
|
2012-05-30 |
2013-12-04 |
AmVac AG |
Method for expression of heterologous proteins using a recombinant negative-strand RNA virus vector comprising a mutated P protein
|
|
AU2013293270B2
(en)
|
2012-07-25 |
2018-08-16 |
Massachusetts Institute Of Technology |
Inducible DNA binding proteins and genome perturbation tools and applications thereof
|
|
EP2792742A1
(en)
|
2013-04-17 |
2014-10-22 |
Universitätsklinikum Hamburg-Eppendorf (UKE) |
Gene-therapy vectors for treating cardiomyopathy
|
|
ES2739288T3
(es)
|
2013-09-13 |
2020-01-30 |
California Inst Of Techn |
Recuperación selectiva
|
|
GB201318347D0
(en)
|
2013-10-16 |
2013-11-27 |
Ucl Business Plc |
Retroviral vectors
|
|
CN105745326A
(zh)
|
2013-10-24 |
2016-07-06 |
优尼科Ip有限公司 |
用于基因治疗神经疾病的aav-5假型载体
|
|
CA2930877A1
(en)
|
2013-11-18 |
2015-05-21 |
Crispr Therapeutics Ag |
Crispr-cas system materials and methods
|
|
WO2015161276A2
(en)
|
2014-04-18 |
2015-10-22 |
Editas Medicine, Inc. |
Crispr-cas-related methods, compositions and components for cancer immunotherapy
|
|
US20170037431A1
(en)
|
2014-05-01 |
2017-02-09 |
University Of Washington |
In vivo Gene Engineering with Adenoviral Vectors
|
|
LT3137497T
(lt)
|
2014-05-02 |
2021-07-26 |
Genzyme Corporation |
Aav vektoriai, skirti tinklainės ir cns genų terapijai
|
|
WO2015188191A1
(en)
|
2014-06-06 |
2015-12-10 |
Wong Wilson W |
Dna recombinase circuits for logical control of gene expression
|
|
US10781459B2
(en)
|
2014-06-20 |
2020-09-22 |
University Of Florida Research Foundation, Incorporated |
Methods of packaging multiple adeno-associated virus vectors
|
|
MA41346A
(fr)
|
2015-01-12 |
2017-11-21 |
Juno Therapeutics Inc |
Eléments régulateurs post-transcriptionnels d'hépatite modifiée
|
|
WO2016118780A1
(en)
|
2015-01-21 |
2016-07-28 |
Fred Hutchinson Cancer Research Center |
Point-of-care and/or portable platform for gene therapy
|
|
KR20240119152A
(ko)
|
2015-03-10 |
2024-08-06 |
더 트러스티스 오브 컬럼비아 유니버시티 인 더 시티 오브 뉴욕 |
재조합 glut1 아데노-관련 바이러스 벡터 작제물 및 glut1 발현을 회복하기 위한 관련된 방법
|
|
EA201792500A1
(ru)
|
2015-05-13 |
2018-04-30 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Aav-опосредованная экспрессия антител против гриппа и способы их использования
|
|
US20170029798A1
(en)
|
2015-07-27 |
2017-02-02 |
Cellivery Therapeutics, Inc. |
Development of Improved Cell-Permeable (iCP) Parkin Recombinant Protein as a Protein-Based Anti-Neurodegenerative Agent for the Treatment of Parkinson's Disease-Associated Phenotypes by Utilizing BBB-Penetrating Protein Delivery System MITT, Enabled by Advanced Macromolecule Transduction Domain (aMTD)
|
|
SG11201803934YA
(en)
|
2015-11-11 |
2018-06-28 |
Intrexon Corp |
Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologies
|
|
KR102423442B1
(ko)
|
2015-12-11 |
2022-07-20 |
캘리포니아 인스티튜트 오브 테크놀로지 |
아데노-관련 바이러스를 지시하기 위한 타겟팅 펩타이드
|
|
PT3405215T
(pt)
|
2016-01-19 |
2022-09-20 |
Univ California |
Métodos para o tratamento da doença de danon e outros transtornos da autofagia
|
|
CA3011939A1
(en)
|
2016-02-02 |
2017-08-10 |
University Of Massachusetts |
Method to enhance the efficiency of systemic aav gene delivery to the central nervous system
|
|
HUE055862T2
(hu)
|
2016-04-20 |
2021-12-28 |
Centro De Investig Energeticas |
Készítmények és eljárások PKLR fokozott génexpressziójára
|
|
CN109757100A
(zh)
*
|
2016-06-29 |
2019-05-14 |
特拉维夫大学拉莫特有限公司 |
用于向中枢神经系统（cns）递送蛋白质的工程改造的寄生虫
|
|
KR20240151726A
(ko)
|
2016-09-08 |
2024-10-18 |
센트로 데 인베스띠가씨오네스 에너제티까스 메디오암비엔딸레스 와이 테크놀로지까스, 오.에이., 엠.피. |
판코니 빈혈 환자를 위한 유전자 치료
|
|
US11338046B2
(en)
|
2016-09-30 |
2022-05-24 |
Esteve Pharmaceuticals, S.A. |
Adenoassociated virus vectors for the treatment of mucopolysaccharidoses
|
|
US20180326022A1
(en)
|
2017-04-21 |
2018-11-15 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for improving heart function and treating heart failure
|
|
WO2018201065A1
(en)
|
2017-04-27 |
2018-11-01 |
Fred Hutchinson Cancer Research Center |
Therapeutic formulations containing cd34+ stem cells derived from negative selection
|
|
SG11202002263TA
(en)
|
2017-10-16 |
2020-04-29 |
Centro De Investigaciones Energeticas Medioambientales Y Tecnologicas |
Lentiviral vectors for delivery of pklr to treat pyruvate kinase deficiency
|
|
WO2019200167A1
(en)
|
2018-04-11 |
2019-10-17 |
Rocket Pharmaceuticals, Ltd. |
Compositions and methods for stem cell transplant
|
|
US20210363193A1
(en)
|
2018-04-27 |
2021-11-25 |
Universität Heidelberg |
Modified aav capsid polypeptides for treatment of muscular diseases
|
|
MX2020011386A
(es)
|
2018-04-27 |
2021-01-29 |
Spacecraft Seven Llc |
Terapia genica para la degeneracion del snc.
|
|
KR102918544B1
(ko)
|
2018-07-12 |
2026-01-27 |
로켓 파마슈티컬스, 리미티드 |
다논병을 치료하기 위한 유전자 요법 벡터
|
|
KR20210046004A
(ko)
|
2018-07-30 |
2021-04-27 |
센트로 데 인베스띠가씨오네스 에너제티까스 메디오암비엔딸레스 와이 테크놀로지까스, 오.에이., 엠.피. |
조혈 세포의 유전자 변형 방법
|
|
EP3833745A1
(en)
|
2018-08-10 |
2021-06-16 |
REGENXBIO Inc. |
Scalable method for recombinant aav production
|
|
BR112021002765A2
(pt)
|
2018-08-16 |
2021-07-20 |
Spacecraft Seven, Llc |
métodos de produção para vetores virais
|
|
BR112021015751A2
(pt)
|
2019-02-12 |
2022-02-08 |
Spacecraft Seven Llc |
Vetores de terapia genética para tratamento da doença de danon
|
|
SG11202112347RA
(en)
|
2019-05-23 |
2021-12-30 |
Spacecraft Seven Llc |
Gene therapy vectors for infantile malignant osteopetrosis
|
|
US12552838B2
(en)
|
2020-04-20 |
2026-02-17 |
Tenaya Therapeutics, Inc. |
Adeno-associated virus with engineered capsid
|
|
CA3177341A1
(en)
|
2020-05-20 |
2021-11-25 |
Chester Bittencort SACRAMENTO |
Engineered parkin and uses thereof
|
|
EP4153760A4
(en)
|
2020-05-21 |
2024-08-21 |
Nysnobio GT, LLC |
GENE THERAPY ADMINISTRATION OF PARKIN MUTANTS WITH ENHANCED ACTIVITY FOR THE TREATMENT OF PARKINSON'S DISEASE
|
|
WO2022017630A1
(en)
|
2020-07-23 |
2022-01-27 |
Ucl Business Ltd |
GENE THERAPY VECTOR FOR eEF1A2 AND USES THEREOF
|
|
KR20230042468A
(ko)
|
2020-08-05 |
2023-03-28 |
스페이스크래프트 세븐, 엘엘씨 |
Csrp3 (시스테인 및 글리신 풍부 단백질 3) 유전자 요법
|
|
CN116113700A
(zh)
|
2020-08-05 |
2023-05-12 |
太空飞船七有限责任公司 |
用于glut1表达的腺相关病毒载体及其用途
|
|
KR20230043869A
(ko)
|
2020-08-07 |
2023-03-31 |
스페이스크래프트 세븐, 엘엘씨 |
Aav 벡터를 사용한 플라코필린-2(pkp2) 유전자 요법
|
|
CN116887868A
(zh)
|
2020-12-07 |
2023-10-13 |
太空飞船七有限责任公司 |
达农病的治疗
|
|
IL314602A
(en)
|
2022-02-08 |
2024-09-01 |
Spacecraft Seven Llc |
Adeno-associated viral vector for GLUT1 expression and uses thereof
|